AGREEMENT TO PROVIDE ADDITIONAL CAPITALAgreement • April 6th, 2006 • Arrowhead Research Corp • Services-commercial physical & biological research • Delaware
THIS AGREEMENT TO PROVIDE ADDITIONAL CAPITAL (this “Agreement”) is made and entered into as of March 31, 2006, by and between ARROWHEAD RESEARCH CORPORATION, a Delaware corporation (“Arrowhead”), and CALANDO PHARMACEUTICALS INC., a Delaware corporation (the “Company”).
COMMON STOCK TRANSFER AGREEMENTCommon Stock Transfer Agreement • April 6th, 2006 • Arrowhead Research Corp • Services-commercial physical & biological research • California
THIS COMMON STOCK TRANSFER AGREEMENT (this “Agreement”) is made as of this 31st day of March, 2006, by and among Calando Pharmaceuticals Inc., a Delaware corporation (the “Company”), Arrowhead Research Corporation, a Delaware corporation (“Investor”), and those individuals set forth on Schedule A attached hereto (each a “Stockholder” and collectively, the “Stockholders”). Capitalized terms used herein which are not defined shall have the meanings ascribed to such terms in the Series A Purchase Agreement (as defined below).
CALANDO PHARMACEUTICALS INC. SERIES A PREFERRED STOCK PURCHASE AGREEMENT March 31, 2006Series a Preferred Stock Purchase Agreement • April 6th, 2006 • Arrowhead Research Corp • Services-commercial physical & biological research • California
THIS SERIES A PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made on the 31st day of March, 2006, among Calando Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Arrowhead Research Corporation, a Delaware corporation (“Investor”).
